# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001370053-25-000002
Filing Date
2025-02-03
Accepted
2025-02-03 08:55:32
Documents
19
Period of Report
2025-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | anab-20250131.htm iXBRL | 8-K | 27888
2 | EX-99.1 | anab-pressrelease2025x01.htm | EX-99.1 | 13945
7 |  | anab-pressrelease2025x01001.jpg | GRAPHIC | 250230
8 |  | anab-pressrelease2025x01002.jpg | GRAPHIC | 291109
9 |  | anab-pressrelease2025x01003.jpg | GRAPHIC | 288998
10 |  | anab-pressrelease2025x01004.jpg | GRAPHIC | 175524
| Complete submission text file | 0001370053-25-000002.txt |  | 1601196

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anab-20250131.xsd | EX-101.SCH | 2058
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | anab-20250131_def.xml | EX-101.DEF | 8934
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anab-20250131_lab.xml | EX-101.LAB | 30000
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anab-20250131_pre.xml | EX-101.PRE | 20656
21 | EXTRACTED XBRL INSTANCE DOCUMENT | anab-20250131_htm.xml | XML | 2817

Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 25580776
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)